By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom said today that the underwriters of its public offering announced yesterday have exercised in full an option to purchase an additional 2.1 million shares of the firm's common stock at a price of $6 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.